Australia TGA ARTG record

Cryogenic spray, cutaneous

Australia TGA ARTG Registered Device · Emergo Asia Pacific Pty Ltd T/a Emergo Australia · CryoConcepts LP · Class IIa · Started June 03, 2021

Good Name: Emergo Asia Pacific Pty Ltd T/a Emergo Australia - Cryogenic spray, cutaneous

Device classification

Risk Class: Class IIa
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: June 03, 2021
Effective Date: June 03, 2021

Sponsor

Name: Emergo Asia Pacific Pty Ltd T/a Emergo Australia

Manufacturer

Name: CryoConcepts LP
Country: United States of America
Address: 1100 Conroy Place, Easton, PA, 18040

Intended purpose

This multi-use disposable device is intended for the removal of target tissue by applying cryogenic gasses at extreme low temperatures. This list below shows examples of the types of lesions that can be treated. • Lentigo (Age Spots) • Skin Tags • Actinic Keratosis (Sun Spots)

About this record

Access comprehensive regulatory information for Cryogenic spray, cutaneous in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Emergo Asia Pacific Pty Ltd T/a Emergo Australia, manufactured by CryoConcepts LP in United States of America. The device registration started on June 03, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.